MEDICINES AND METHODS OF TREATMENT OF PRESBIOPIA, MODERATE HYPERMETROPY AND INCORRECT ASTIGMATISM

摘要

1. A medicament for treating an eye condition comprising an Muscarinic Acetylcholine Mi receptor agonist, at least one of the following: an alpha stimulating agonist containing an imidazoline group; or non-steroidal anti-inflammatory drug (NSAID), which is selective for COX-2; characterized in that the condition of the eyes includes presbyopia, moderate hyperopia, irregular astigmatism, hyperopic accommodation esotropia or glaucoma. 2. The drug according to claim 1, characterized in that the drug contains: from about 0.01 to about 4% wt./wt. muscarinic acetylcholine receptor agonist M; iot from about 0.01% to about 0.5% wt./wt. an alpha-stimulating agonist containing an imidazoline group, or from about 0.01 to about 2% NSAIDs, having selectivity for COX-2, or both. The drug according to claim 1, characterized in that the drug contains: from about 0.01 to about 2% wt./wt. agonist muscarinic acetylcholine receptor Miot from about 0.01 to about 0.2% wt./wt. an alpha-stimulating agonist containing an imidazoline group, or from about 0.01 to about 1% NSAIDs, having selectivity for COX-2, or both. The drug according to claim 1, characterized in that the drug contains: from about 0.5 to about 1.5% wt./wt. agonist muscarinic acetylcholine receptor Miot about 0.02 to about 0.1% wt./wt. an alpha-stimulating agonist containing an imidazoline group or an NSAID that has selectivity for COX-2.5. The drug according to any one of paragraphs. 1-4, characterized in that the muscarinic acetylcholine receptor agonist